ONYX PHARMACEUTICALS

Serial Number 85185041
606

Registration Progress

Application Filed
Nov 24, 2010
Under Examination
Dec 20, 2011
Approved for Publication
Oct 25, 2011
Published for Opposition
Oct 25, 2011
Registered

Trademark Image

ONYX PHARMACEUTICALS

Basic Information

Serial Number
85185041
Filing Date
November 24, 2010
Published for Opposition
October 25, 2011
Abandonment Date
July 21, 2014
Drawing Code
3000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jul 21, 2014
Classes
042

Rights Holder

Onyx Pharmaceuticals, Inc.

03
Address
249 E. Grand Avenue
South San Francisco, CA 94080

Ownership History

Onyx Pharmaceuticals, Inc.

Original Applicant
03
South San Francisco, CA

Onyx Pharmaceuticals, Inc.

Owner at Publication
03
South San Francisco, CA

Legal Representation

Attorney
Richard M. LaBarge

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

41 events
Date Code Type Description Documents
Jul 21, 2014 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jul 21, 2014 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Feb 20, 2014 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Feb 20, 2014 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Nov 19, 2013 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 18, 2013 EX4G S SOU EXTENSION 4 GRANTED Loading...
Nov 14, 2013 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 14, 2013 EXT4 S SOU EXTENSION 4 FILED Loading...
Jul 2, 2013 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 1, 2013 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jun 28, 2013 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jun 4, 2013 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 4, 2013 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 4, 2013 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 25, 2012 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 24, 2012 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 22, 2012 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 22, 2012 EXT2 S SOU EXTENSION 2 FILED Loading...
Jul 12, 2012 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 11, 2012 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jul 11, 2012 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 18, 2012 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 18, 2012 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 20, 2011 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 25, 2011 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 25, 2011 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 22, 2011 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Sep 21, 2011 ALIE A ASSIGNED TO LIE Loading...
Sep 8, 2011 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 7, 2011 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 7, 2011 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 7, 2011 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 19, 2011 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
May 19, 2011 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Mar 7, 2011 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 7, 2011 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 7, 2011 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 3, 2011 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 1, 2010 MDSC O NOTICE OF DESIGN SEARCH CODE MAILED Loading...
Nov 30, 2010 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 27, 2010 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Pharmaceutical research and development; medical and scientific research, namely, conducting clinical trials; medical and scientific research in the fields of treatment for cancer and oncology, and in the fields of treatment of inflammation and autoimmune diseases
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Design Mark
The mark consists of two curved lines that partially intersect at one point with the words "ONYX PHARMACEUTICALS" to the right of the curved lines.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMACEUTICALS"